cvt 124 has been researched along with Disease Models, Animal in 4 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gottlieb, SS | 1 |
| Dalsey, WC; De Garavilla, L; Gao, E; Kaplan, JL; Minczak, B; Victain, M | 1 |
| Auchampach, JA; Ge, ZD; Gross, GJ; Jin, X; Kiesman, W; Kreckler, LM; Moore, J; Narayanan, J; Smits, G; Ticho, B; Wan, TC; Whalley, E | 1 |
| Dalsey, WC; de Garavilla, L; Gao, E; Kaplan, JL; Victain, MS | 1 |
1 review(s) available for cvt 124 and Disease Models, Animal
| Article | Year |
|---|---|
Adenosine A1 antagonists and the cardiorenal syndrome.
Topics: Adenosine A1 Receptor Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Diseases; Kidney Function Tests; Male; Mice; Prognosis; Randomized Controlled Trials as Topic; Receptor, Adenosine A1; Risk Assessment; Severity of Illness Index; Syndrome; Treatment Outcome; Xanthines | 2008 |
3 other study(ies) available for cvt 124 and Disease Models, Animal
| Article | Year |
|---|---|
Adenosine A1 antagonism attenuates atropine-resistant hypoxic bradycardia in rats.
Topics: Adenosine A1 Receptor Antagonists; Animals; Atropine; Bradycardia; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Diseases; Hypoxia; Prospective Studies; Rats; Survival Analysis; Vagotomy; Xanthines | 2003 |
Comparison of three different A1 adenosine receptor antagonists on infarct size and multiple cycle ischemic preconditioning in anesthetized dogs.
Topics: Adenosine A1 Receptor Antagonists; Anesthesia; Animals; Disease Models, Animal; Dogs; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Radioligand Assay; Receptor, Adenosine A2A; Xanthines | 2004 |
Adenosine A1 antagonism attenuates beta-adrenergic-resistant sudden hypoxic cardiac insufficiency.
Topics: Acute Disease; Adenosine A1 Receptor Antagonists; Adrenergic beta-Agonists; Aminophylline; Animals; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Dose-Response Relationship, Drug; Heart Diseases; Hemodynamics; Hypoxia; Male; Pilot Projects; Rats; Rats, Sprague-Dawley; Survival Analysis; Treatment Outcome; Xanthines | 2005 |